Solid tumor targeted NGS panel

Alphabetical Test listing

Solid tumor targeted NGS panel-Pathology add-on

Test name:

Test number:

Pathology add-on

Abbreviation:

FOCUS

Alternate names:

Hot spot mutations
Next Generation Sequencing
Oncomine focus assay

Tests included:

52 genes

Useful for:

Next Generation Sequencing (NGS) for the detection of alterations in solid tumors is critical for cancer care as these findings can direct the optimal use of targeted therapies for patients.

Limitations:

If blocks more than 5 years old are submitted for testing, extraction will be attempted, but if insufficient RNA/DNA is retrieved, testing will be cancelled

Specimen type:

Tumor tissue

Transport container:

Formalin-fixed paraffin-embedded (FFPE) tissue block

Alternate transport container:

Cytology slide

Required forms/information:

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

Transport and stability:

Ambient

Reason for rejection:

Improper label (unlabeled or mislabeled)
Improper storage
Interfering substances
Slides broken beyond repair

Performing lab:

AHL - Molecular Diagnostics: D

Days set up:

Varies

TAT:

10 business days

Method:

Next Generation Sequencing

Reference ranges:

No variations detected

Clinical information:

Fusion coverage table

Mutation coverage table

Preauthorization:

This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.

CPT codes:

81455 - NGS: targeted genomic sequence analysis panel, solid organ 51 or greater genes

Subject to medical necessity (Y/N):

Yes

LCD/NCD:

Other billing information:

Medical necessity

Molecular Medicare billing request

Date created:

12/09/2020

Revised date:

05/15/2024

Review date:

01/15/2024